177 related articles for article (PubMed ID: 16565906)
1. Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.
Stone DM; Frattarelli DA; Karthikeyan S; Johnson YR; Chintala K
Pediatr Cardiol; 2006; 27(3):360-3. PubMed ID: 16565906
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic prediction of neonatal ECMO outcome.
Gotteiner NL; Harper WR; Gidding SS; Berdusis K; Wiley AM; Reynolds M; Benson DW
Pediatr Cardiol; 1997; 18(4):270-5. PubMed ID: 9175523
[TBL] [Abstract][Full Text] [Related]
4. [Effect of preoperative administration of prostaglandin E1 on cerebral blood flow in newborns with ductal-dependent congenital cardiac malformations].
Simon M; Cucerea M; Dimitriu AG; Stamatin M
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):399-407. PubMed ID: 20700975
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
6. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
Reddy SC; Saxena A
Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
[TBL] [Abstract][Full Text] [Related]
9. Effect of Long-term Administration of Prostaglandin E
Iwaki R; Matsuhisa H; Minamisawa S; Akaike T; Hoshino M; Yagi N; Morita K; Shinohara G; Kaneko Y; Yoshitake S; Takahashi M; Tsukube T; Oshima Y
Ann Thorac Surg; 2020 Dec; 110(6):2088-2095. PubMed ID: 32246933
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
[TBL] [Abstract][Full Text] [Related]
11. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
12. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
Leonhardt A; Schweer H; Wolf D; Seyberth HW
Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
Ohara T; Ogata H; Fujiyama J; Murata Y; Abe J; Kakuta K; Hayamizu S; Kameyama S; Yoshida Y
Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
[TBL] [Abstract][Full Text] [Related]
14. Fate of the "opened" arterial duct: Lessons learned from bilateral pulmonary artery banding for hypoplastic left heart syndrome under the continuous infusion of prostaglandin E1.
Mitani Y; Takabayashi S; Sawada H; Ohashi H; Hayakawa H; Ikeyama Y; Imanaka-Yoshida K; Maruyama K; Shimpo H; Komada Y
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1653-4. PubMed ID: 17532977
[No Abstract] [Full Text] [Related]
15. Response to prostaglandin E1 in neonates with intracranial arteriovenous malformation treated for suspected congenital heart disease.
Covert RF
Pediatr Cardiol; 1994; 15(2):81-4. PubMed ID: 7997419
[TBL] [Abstract][Full Text] [Related]
16. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease.
Yucel IK; Cevik A; Bulut MO; Dedeoğlu R; Demir İH; Erdem A; Celebi A
Cardiol Young; 2015 Jan; 25(1):56-62. PubMed ID: 24168719
[TBL] [Abstract][Full Text] [Related]
18. Case report 701: Prostaglandin E1 (PGE1) periostitis.
Rowley RF; Lawson JP
Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
[TBL] [Abstract][Full Text] [Related]
19. Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey.
Ustün N; Dilli D; Zenciroğlu A; Okumuş N; Cınar G; Ozgür S; Koç M
Anadolu Kardiyol Derg; 2013 Nov; 13(7):732-4. PubMed ID: 24172809
[No Abstract] [Full Text] [Related]
20. The significance of ductal shunting during extracorporeal membrane oxygenation.
Burch KD; Covitz W; Lovett EJ; Howell C; Kanto WP
J Pediatr Surg; 1989 Sep; 24(9):855-9. PubMed ID: 2778580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
